Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy

American Journal of Hypertension

Volumn 18, Issue 1, 2005, Pages 18-22

  Manolis, Athanasios J ^a,b   Iraklianou, Stella ^a   Pittaras, Andreas ^a   Zaris, Michael ^a   Tsioufis, Konstantinos ^a   Psaltiras, George ^a   Psomali, Demetra ^a   Foussas, Stefanos ^a   Gavras, Irene ^b   Gavras, Haralambos ^b  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arterial wall stiffness; diabetes mellitus; perindopril therapy; pulse wave velocity

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ADULT; ARTERY COMPLIANCE; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SCREENING; DRUG USE; ENZYME INHIBITION; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETER; PATIENT; PRIORITY JOURNAL; PULSE WAVE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIES; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPLIANCE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PERINDOPRIL; TREATMENT OUTCOME;

EID: 19944433342     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.08.014     Document Type: Article

References (29)

1. K. Pyorala, M. Laasko, M. Uusitupa Diabetes and atherosclerosis an epidemiological view Diabetes Metab Rev 3 1987 463 524
2. F. de Vegt, J.M. Dekker, H.G. Ruhe, C.D. Stehouwer, G. Nijpels, L.M. Bouter, R.J. Heine Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population the Hoorn Study Diabetologia 42 1999 926 931
3. N. Westerhof, M.F. O' Rourke Hemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy J Hypertens 13 1995 943 952
4. J. Blacher, A.P. Guerin, B. Pannier, S.J. Marchais, M.E. Safar, G.M. London Impact of aortic stiffness on survival in end stage renal disease Circulation 99 1999 2434 2439
5. J. Blacher, S. Asmar, S. Djane, G.M. London, M.E. Safar Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients Hypertension 33 1999 1111 1117
6. A. Benetos, S. Laurent, R. Asmar, P. Lacolley Large artery stiffness in hypertension J Hypertens 15 Suppl 2 1997 S89 S97
7. R. Asmar, A. Benetos, K. Chaouche-Teyara, C.M. Raveau-Landon, M.E. Safar Comparison of effects of felodipine vs HCTZ on arterial diameter and pulse wave velocity in arterial hypertension Am J Cardiol 72 1993 794 798
8. R. Asmar, G. London, M. O'Rourke, M.E. Safar Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients Hypertension 38 2001 922 926
9. R. Asmar, J. Topouchian, B. Pannier, A. Benetos, M. Safar Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study J Hypertens 19 2001 813 818
10. R. Asmar, A. Benetos, J. Topoucian, P. Laurent, B. Pannier, A.M. Brisac, R. Target, B.I. Levy Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies Hypertension 26 1995 485 490
11. V. Salomaa, W. Riley, J.D. Kark, C. Nardo, A.R. Folsom Non-insulin dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness index. The ARIC study Circulation 91 1995 1432 1443
12. G. McVeigh, G. Brennan, R. Hayes, J. Cohn, S. Finkelstein, D. Johnston Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis Am J Med 95 1993 424 430
13. K.D. Hopkins, E.D. Lehmann, R.L. Johnes, R.C. Turay, R.G. Gosling A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects Diabetes Care 19 1996 501 503
14. R.M.A. Henry, P.J. Kostense, A.M.W. Spijkerman, J.M. Dekker, G. Nijpels, R.J. Heine, O. Kamp, N. Westerhof, L.M. Bouter, C.D.A. Stehouwer Arterial stiffness increase with deteriorating glucose tolerance status. The Hoorn study Circulation 107 2003 2089 2095
15. R.H. Eckel, M. Wassef, A. Chait, B. Sobel, E. Barret, G. King, M. Lopes-Virella, J. Reush, N. Ruderman, G. Steiner, H. Vlassara Prevention Conference VI: diabetes and cardiovascular disease. Writing group II: pathogenesis of atherosclerosis in diabetes Circulation 105 2002 e138 e143
16. H. Kato, H. Suzuki, S. Tajima, Y. Ogata, T. Tominaga, A. Sato, T. Saruta Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells J Hypertens 9 1991 17 22
17. G.H. Gibbons, R.E. Pratt, V.J. Djau Vascular smooth muscle cell hypertrophy vs. hyperplasia autocrine transforming growth factor-β1 expression determines growth response to angiotensin II J Clin Invest 90 1992 456 461
18. B. Levy, P. Curmi, P. Poitevin, M.E. Safar Modification of the arterial mechanical properties of normotensive and hypertensive rats without arterial pressure changes J Cardiovasc Pharmacol 14 1989 253 259
19. P. Albaladejo, H. Bouaziz, M. Duriez, P. Gohlke, B. Levy, M. Safar, A. Benetos Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats Hypertension 23 1994 74 82
20. R.G. Asmar, H.J. Journo, P.J. Lacolley, J.P. Santoni, E. Billaud, B.I. Levy, M. Safar Treatment one year with perindopril effect on cardiac mass and arterial compliance in essential hypertension J Hypertens 6 Suppl 3 1988 S33 S39
21. A.M. Dart, C.M. Reid, B. McGrath Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension Am J Hypertens 14 2001 804 810
22. A. Mahmud, J. Feely Favorable effects on arterial waveform reflection and resistant hypertension J Hum Hypertens 14 2000 541 546
23. HOPE Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
24. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
25. The EUROPA Investigators Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease randomised, double blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788
26. B. Dahlof, R.B. Devereux, S.E. Kjeldsen, S. Julius, G. Beevers, U. de Faire, F. Fyhrquist, H. Ibsen, K. Kristiansson, O. Lederballe-Pedersen, L.H. Lindholm, M.S. Nieminen, P. Omvik, S. Oparil, H. Wedel Life study group Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (Life) a randomized trial against atenolol Lancet 359 2002 995 1003
27. HOPE Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and MICRO-HOPE substudy Lancet 355 2000 253 259
28. L.H. Lindholm, H. Ibsen, B. Dahlof, R.B. Devereux, G. Beevers, U. de Faire, F. Fyhrquist, S. Julius, S.E. Kjeldsen, K. Kristiansson, O. Lederballe-Pedersen, M.S. Nieminen, P. Omvik, S. Oparil, H. Wedel, P. Aurup, J. Edelman, S. Snapinn LIFE study group Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE) a randomised trial against atenolol Lancet 359 2002 1004 1010
29. L. Ghiadoni, A. Magagna, D. Versari, I. Kardasz, Y. Huang, S. Taddei, A. Salvetti Different effect of antihypertensive drugs on conduit artery endothelial function Hypertension 41 2003 1281 1286